BioXcel stock skyrockets 73%: What’s next for investors?
BioXcel Therapeutics, Inc. (NASDAQ: BTAI) shares skyrocketed by 73.61%, closing at $3.75 yesterday, March 3, 2025, after significant regulatory news and regained Nasdaq compliance. However, pre-market...